Here's Why You Should Retain Emerson Stock in Your Portfolio Now

18.11.24 15:47 Uhr

Werte in diesem Artikel
Aktien

13,80 EUR -0,10 EUR -0,72%

Emerson Electric Co. EMR is poised to gain from solid momentum in the Intelligent Devices and Software and Control segments. The company’s measures to reward its shareholders are encouraging.Based in St. Louis, MO, Emerson is a diversified global engineering and technology company. It offers a wide range of products and services to customers in the consumer, commercial and industrial markets. The company boasts a diverse range of brands like Bettis, Crosby, Fisher, Flexim, Micro Motion, Afag, Appleton, ASCO, Greenlee, Klauke, AMS and DeltaV.EMR currently carries a Zacks Rank #3 (Hold). In the past year, the stock has gained 42.8% compared with the industry’s 28.6% growth.Image Source: Zacks Investment ResearchLet’s discuss the factors that should influence investors to retain this company for the time being.Business Strength: Emerson has been experiencing healthy demand across most of its end markets. Solid demand in the process and hybrid industries is boosting underlying sales. The company anticipates sales in the process and hybrid industry to grow moderately in fiscal 2025, driven by strength in the energy, LNG and power end markets. Robust demand from sustainability and digital transformation initiatives will also contribute to steady progress.Also, the company is benefiting from the strong performance of the Intelligent Devices and Software and Control segments. Within the Intelligent Devices segment, it is seeing strength in the Final Control business, driven by solid momentum in the energy and power end markets. Robust growth in all geographies and strong backlog conversion levels are aiding the Measurement & Analytical business. Within the Software and Control segment, strength in the power, process and hybrid end markets is supporting the Control Systems & Software business. Strength in the aerospace and defense end markets, driven by increasing government spending, is supporting the Test & Measurement business’ growth.Expansion Efforts: EMR’s expansion initiative is expected to drive growth. In November 2024, it proposed to acquire the remaining shares of AspenTech for $240 per share. This follows Emerson's 55% majority stake in AspenTech, acquired in 2022, and will increase its ownership to 100%, making AspenTech a wholly owned subsidiary. In the fourth quarter of fiscal 2023, the company completed the acquisitions of Afag and Flexim. The buyout of Afag boosted Emerson’s capabilities in factory automation, helping it expand into lucrative end markets, battery manufacturing, automotive, packaging, medical, life sciences and electronics. The acquisition of Flexim added to its existing flow measurement positions in coriolis, differential pressure, magmeter and vortex flow measurement and expanded its automation portfolio and measurement capabilities.Rewards to Shareholders: The company’s measures to reward its shareholders through dividend payments are noteworthy. In 2024 (ended September 2024), it paid out dividends of $1.2 billion and repurchased common stocks worth $435 million. In November 2024, the company hiked its dividend by 0.5%. Emerson plans to repurchase shares worth $2 billion and pay out dividends of $1.2 billion in fiscal 2025 (ending September 2025). For fiscal 2025, it expects free cash flow to be in the band of $3.2–$3.3 billion.Downsides of EMRRising Costs: Emerson has been dealing with the adverse impacts of the high cost of sales and operating expenses. Increasing material and freight costs are pushing up the cost of sales, which surged 8.2% in the fourth quarter of fiscal 2024. The impact of these expenditures is evident in the rise of the cost of sales as a percentage of total revenues, which climbed 210 basis points to reach 50.8%. Selling, general and administrative expenses increased 18% to $1.3 billion due to increased acquisition-related and stock compensation expenses.Forex Woes: The company’s operations are spread across the world, the majority of which are outside the United States. Therefore, it is exposed to global economic and political risks as well as unfavorable movement in foreign currencies.Stocks to ConsiderSome better-ranked companies are discussed below.Graham Corporation GHM currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.GHM delivered a trailing four-quarter average earnings surprise of 101.9%. In the past 60 days, the Zacks Consensus Estimate for Graham’s fiscal 2025 earnings has increased 8.4%.RBC Bearings Incorporated RBC presently carries a Zacks Rank #2 (Buy). The company delivered a trailing four-quarter average earnings surprise of 2.5%.In the past 60 days, the consensus estimate for RBC’s fiscal 2025 earnings has increased 2.3%.Kadant Inc. KAI presently carries a Zacks Rank of 2. It has a trailing four-quarter average earnings surprise of 17.2%. The Zacks Consensus Estimate for KAI’s 2024 earnings has increased 1.8% in the past 60 days.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Emerson Electric Co. (EMR): Free Stock Analysis Report RBC Bearings Incorporated (RBC): Free Stock Analysis Report Kadant Inc (KAI): Free Stock Analysis Report Graham Corporation (GHM): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf NOW

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOW

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu NOW Inc When Issued

Analysen zu NOW Inc When Issued

DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
16.01.2018NOW BuyStifel, Nicolaus & Co., Inc.
06.06.2017NOW BuyStifel, Nicolaus & Co., Inc.
04.05.2017NOW BuySeaport Global Securities
DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW Market PerformCowen and Company, LLC
02.11.2017NOW Market PerformCowen and Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für NOW Inc When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"